A defect in cholesterol esterification in Niemann-Pick disease (type C) patients.

Peter G. Pentchev(National Institutes of Health), Marcella Comly(National Institutes of Health), Howard S. Kruth(National Institutes of Health), M. T. Vanier, David A. Wenger, Shaun R. Patel, Roscoe O. Brady(National Institutes of Health)
Proceedings of the National Academy of Sciences
December 1, 1985
Cited by 397Open Access
Full Text

Abstract

The demonstration of a defect of cholesterol esterification in a mutant strain of BALB/c mice with an attendant reduction of sphingomyelinase activity [Pentchev, P. G., Boothe, A. D., Kruth, H.S., Weintroub, H., Stivers, J. & Brady, R. O. (1984) J. Biol. Chem. 259, 5784-5791] prompted us to examine the capacity of cultured human Niemann-Pick fibroblasts to esterify exogenously derived cholesterol. Cholesterol was supplied to cell cultures in the form of native or chemically modified, positively charged low density lipoprotein or as non-lipoprotein cholesterol. Cholesterol esterification was not impaired in cell cultures derived from patients with type A or B Niemann-Pick disease. However, esterification of exogenously administered cholesterol was deficient in 20 type C Niemann-Pick cell lines that were available for testing. Fluorescence histochemical staining of unesterified cholesterol in type C cells suggested that these cells were able to internalize and lysosomally process lipoprotein cholesterol. Acyl-CoA:cholesterol acyltransferase activity did not appear deficient in type C cell extracts. The error in cholesterol esterification may provide an opportunity for probing the molecular lesion in this disorder and may afford a useful and reliable means for establishing diagnosis.


Related Papers

No related papers found

Powered by citation graph analysis